Recomendaciones para su abordaje clínico | 10 ENE 20

Incidentalomas suprarrenales

En esta actualización clínica, los autores destacan el abordaje de los tumores suprarrenales incidentales según las directrices internacionales
Autor/a: Hanna F, Issa B, Fryer A y colaboradores BMJ 360(-):1-9, Ene 2018
INDICE:  1. Página 1 | 2. Página 2
Página 2

Referencias

1 YoungWFJr. Management approaches to adrenal incidentalomas. A view from Rochester, Minnesota. Endocrinol Metab Clin North Am2000;29:159-85, x. doi:10.1016/S0889-8529(05)70122-510732270

2 TerzoloMStiglianoAChiodiniIItalian Association of Clinical Endocrinologists. AME position statement on adrenal incidentaloma. Eur J Endocrinol2011;164:851-70. doi:10.1530/EJE-10-114721471169

3 MansmannGLauJBalkERothbergMMiyachiYBornsteinSR. The clinically inapparent adrenal mass: update in diagnosis and management. Endocr Rev2004;25:309-40. doi:10.1210/er.2002-003115082524

4 FassnachtMArltWBancosI. Management of adrenal incidentalomas: European Society of Endocrinology clinical practice guideline in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol2016;175:G1-34. doi:10.1530/EJE-16-046727390021

5 GrumbachMMBillerBMKBraunsteinGD. Management of the clinically inapparent adrenal mass (“incidentaloma”). Ann Intern Med2003;138:424-9. doi:10.7326/0003-4819-138-5-200303040-0001312614096

6 KloosRTGrossMDFrancisIRKorobkinMShapiroB. Incidentally discovered adrenal masses. Endocr Rev1995;16:460-84.8521790

7 BarzonLSoninoNFalloFPaluGBoscaroM. Prevalence and natural history of adrenal incidentalomas. Eur J Endocrinol2003;149:273-85. doi:10.1530/eje.0.149027314514341

8 BovioSCataldiAReimondoG. Prevalence of adrenal incidentaloma in a contemporary computerized tomography series. J Endocrinol Invest2006;29:298-302. doi:10.1007/BF0334409916699294

9 MayerSKOlignyLLDealCYazbeckSGagnéNBlanchardH. Childhood adrenocortical tumors: case series and reevaluation of prognosis--a 24-year experience. J Pediatr Surg1997;32:911-5. doi:10.1016/S0022-3468(97)90649-79200099

10 YoungWFJr. Clinical practice. The incidentally discovered adrenal mass. N Engl J Med2007;356:601-10. doi:10.1056/NEJMcp06547017287480

11 SuttonMGShepsSGLieJT. Prevalence of clinically unsuspected pheochromocytoma. Review of a 50-year autopsy series. Mayo Clin Proc1981;56:354-60.6453259

12 ZeigerMAThompsonGBDuhQYAmerican Association of Clinical EndocrinologistsAmerican Association of Endocrine Surgeons. The American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons medical guidelines for the management of adrenal incidentalomas. Endocr Pract2009;15(Suppl 1):1-20. doi:10.4158/EP.15.S1.119632967

13 KapoorAMorrisTRebelloR. Guidelines for the management of the incidentally discovered adrenal mass. Can Urol Assoc J2011;5:241-7. doi:10.5489/cuaj.1113521801680

14 ManteroFTerzoloMArnaldiGStudy Group on Adrenal Tumors of the Italian Society of Endocrinology. A survey on adrenal incidentaloma in Italy. J Clin Endocrinol Metab2000;85:637-44.10690869

15 NIH state-of-the-science statement on management of the clinically inapparent adrenal mass (“incidentaloma”). NIH Consens State Sci Statements2002;19:1-25.14768652

 

Comentarios

Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

AAIP RNBD
Términos y condiciones de uso | Todos los derechos reservados | Copyright 1997-2022